Results: 1-25 | 26-32

Table of contents of journal: *Journal of clinical oncology

Results: 1-25/32

Authors: MARKMAN M HOSKINS W
Citation: M. Markman et W. Hoskins, RESPONSES TO SALVAGE CHEMOTHERAPY IN OVARIAN-CANCER - A CRITICAL NEEDFOR PRECISE DEFINITIONS OF THE TREATED POPULATION, Journal of clinical oncology, 10(4), 1992, pp. 513-514

Authors: OCONNELL MJ
Citation: Mj. Oconnell, ETOPOSIDE, DOXORUBICIN, AND CISPLATIN CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER - AN OLD LESSON REVISITED, Journal of clinical oncology, 10(4), 1992, pp. 515-516

Authors: DAVIDSON NE
Citation: Ne. Davidson, OUT OF THE COURTROOM AND INTO THE CLINIC, Journal of clinical oncology, 10(4), 1992, pp. 517-519

Authors: JODRELL DI EGORIN MJ CANETTA RM LANGENBERG P GOLDBLOOM EP BURROUGHS JN GOODLOW JL TAN S WILTSHAW E
Citation: Di. Jodrell et al., RELATIONSHIPS BETWEEN CARBOPLATIN EXPOSURE AND TUMOR RESPONSE AND TOXICITY IN PATIENTS WITH OVARIAN-CANCER, Journal of clinical oncology, 10(4), 1992, pp. 520-528

Authors: SCAMBIA G PANICI PB BATTAGLIA F FERRANDINA G BAIOCCHI G GREGGI S DEVINCENZO R MANCUSO S
Citation: G. Scambia et al., SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 10(4), 1992, pp. 529-535

Authors: LERNER A GONIN R STEELE GD MAYER RJ
Citation: A. Lerner et al., ETOPOSIDE, DOXORUBICIN, AND CISPLATIN CHEMOTHERAPY FOR ADVANCED GASTRIC ADENOCARCINOMA - RESULTS OF A PHASE-II TRIAL, Journal of clinical oncology, 10(4), 1992, pp. 536-540

Authors: KELSEN D ATIQ OT SALTZ L NIEDZWIECKI D GINN D CHAPMAN D HEELAN R LIGHTDALE C VINCIGUERRA V BRENNAN M
Citation: D. Kelsen et al., FAMTX VERSUS ETOPOSIDE, DOXORUBICIN, AND CISPLATIN - A RANDOM ASSIGNMENT TRIAL IN GASTRIC-CANCER, Journal of clinical oncology, 10(4), 1992, pp. 541-548

Authors: WOOLLEY PV NAUTA R SMITH FP LINDBLAD AS PETRELLI N HERRERA L DOUGLASS HO MAYER RJ BRUCKNER HW DALTON J BONADONNA G GENNARI L HALL TC WEAVER DW LEICHMAN L KALSER MH BENEDETTO P MUGGIA FM GREEN M GREENWALD E LEVIN B GAYNOR E HARRIS J MARSH JC BARWICK K KNOWLTON AH LIVSTONE EM BUKOWSKI RM LOUTFI A RAMIREZ G THOMAS PRM
Citation: Pv. Woolley et al., RADIATION-THERAPY AND FLUOROURACIL WITH OR WITHOUT SEMUSTINE FOR THE TREATMENT OF PATIENTS WITH SURGICAL ADJUVANT ADENOCARCINOMA OF THE RECTUM, Journal of clinical oncology, 10(4), 1992, pp. 549-557

Authors: NICHOLS CR ANDERSEN J LAZARUS HM FISHER H GREER J STADTMAUER EA LOEHRER PJ TRUMP DL
Citation: Cr. Nichols et al., HIGH-DOSE CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN REFRACTORY GERM-CELL CANCER - AN EASTERN COOPERATIVE ONCOLOGY GROUP PROTOCOL, Journal of clinical oncology, 10(4), 1992, pp. 558-563

Authors: STURGEON JFG JEWETT MAS ALISON RE GOSPODAROWICZ MK BLEND R HERMAN S RICHMOND H THOMAS G DUNCAN W MUNRO A
Citation: Jfg. Sturgeon et al., SURVEILLANCE AFTER ORCHIECTOMY FOR PATIENTS WITH CLINICAL STAGE-I NONSEMINOMATOUS TESTIS TUMORS, Journal of clinical oncology, 10(4), 1992, pp. 564-568

Authors: FOSSA SD QVIST H STENWIG AE LIEN HH OUS S GIERCKSKY KE
Citation: Sd. Fossa et al., IS POSTCHEMOTHERAPY RETROPERITONEAL SURGERY NECESSARY IN PATIENTS WITH NONSEMINOMATOUS TESTICULAR CANCER AND MINIMAL RESIDUAL TUMOR MASSES, Journal of clinical oncology, 10(4), 1992, pp. 569-573

Authors: OSANTO S BUKMAN A VANHOEK F STERK PJ DELAAT JAPM HERMANS J
Citation: S. Osanto et al., LONG-TERM EFFECTS OF CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER, Journal of clinical oncology, 10(4), 1992, pp. 574-579

Authors: BURKES RL GINSBERG RJ SHEPHERD FA BLACKSTEIN ME GOLDBERG ME WATERS PF PATTERSON GA TODD T PEARSON FG COOPER JD JONES D LOCKWOOD G
Citation: Rl. Burkes et al., INDUCTION CHEMOTHERAPY WITH MITOMYCIN, VINDESINE, AND CISPLATIN FOR STAGE-III UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF THE TORONTO PHASE-II TRIAL, Journal of clinical oncology, 10(4), 1992, pp. 580-586

Authors: DIMOPOULOS MA GOLDSTEIN J FULLER L DELASALLE K ALEXANIAN R
Citation: Ma. Dimopoulos et al., CURABILITY OF SOLITARY BONE PLASMACYTOMA, Journal of clinical oncology, 10(4), 1992, pp. 587-590

Authors: FRANCINI G GONNELLI S PETRIOLI R CONTI F PAFFETTI P GENNARI C
Citation: G. Francini et al., TREATMENT OF BONE METASTASES WITH DICHLOROMETHYLENE BISPHOSPHONATE, Journal of clinical oncology, 10(4), 1992, pp. 591-598

Authors: ALLRED DC CLARK GM TANDON AK MOLINA R TORMEY DC OSBORNE CK GILCHRIST KW MANSOUR EG ABELOFF M EUDEY L MCGUIRE WL
Citation: Dc. Allred et al., HER-2 NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OFOVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA/, Journal of clinical oncology, 10(4), 1992, pp. 599-605

Authors: TRUEWORTHY R SHUSTER J LOOK T CRIST W BOROWITZ M CARROLL A FRANKEL L HARRIS M WAGNER H HAGGARD M MOSIJCZUK A PULLEN J STEUBER P LAND V
Citation: R. Trueworthy et al., PLOIDY OF LYMPHOBLASTS IS THE STRONGEST PREDICTOR OF TREATMENT OUTCOME IN B-PROGENITOR CELL ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC ONCOLOGY GROUP-STUDY, Journal of clinical oncology, 10(4), 1992, pp. 606-613

Authors: HEYN R RANEY RB HAYS DM TEFFT M GEHAN E WEBBER B MAURER HM
Citation: R. Heyn et al., LATE EFFECTS OF THERAPY IN PATIENTS WITH PARATESTICULAR RHABDOMYOSARCOMA, Journal of clinical oncology, 10(4), 1992, pp. 614-623

Authors: WOFFORD MM SMITH SD SHUSTER JJ JOHNSON W BUCHANAN GR WHARAM MD RITCHEY AK ROSEN D HAGGARD ME GOLEMBE BL RIVERA GK
Citation: Mm. Wofford et al., TREATMENT OF OCCULT OR LATE OVERT TESTICULAR RELAPSE IN CHILDREN WITHACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY, Journal of clinical oncology, 10(4), 1992, pp. 624-630

Authors: HERRMANN F HELFRICH SG LINDEMANN A SCHLEIERMACHER E HUBER C MERTELSMANN R
Citation: F. Herrmann et al., ELEVATED CIRCULATING LEVELS OF TUMOR-NECROSIS-FACTOR PREDICT UNRESPONSIVENESS TO TREATMENT WITH INTERFERON ALFA-2B IN CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 10(4), 1992, pp. 631-634

Authors: DEANGELIS LM YAHALOM J THALER HT KHER U
Citation: Lm. Deangelis et al., COMBINED MODALITY THERAPY FOR PRIMARY CNS LYMPHOMA, Journal of clinical oncology, 10(4), 1992, pp. 635-643

Authors: VERDONCK LF DEKKER AW DEGAST GC LOKHORST HM NIEUWENHUIS HK
Citation: Lf. Verdonck et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULT POOR-RISK LYMPHOBLASTIC LYMPHOMA IN 1ST REMISSION, Journal of clinical oncology, 10(4), 1992, pp. 644-646

Authors: ROWINSKY EK GROCHOW LB HENDRICKS CB ETTINGER DS FORASTIERE AA HUROWITZ LA MCGUIRE WP SARTORIUS SE LUBEJKO BG KAUFMANN SH DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR, Journal of clinical oncology, 10(4), 1992, pp. 647-656

Authors: EDDY DM
Citation: Dm. Eddy, HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF METASTATIC BREAST-CANCER, Journal of clinical oncology, 10(4), 1992, pp. 657-670

Authors: CHEUNG NKV LAZARUS H MIRALDI FD BERGER NA ABRAMOWSKY CR SAARINEN UM SPITZER T STRANDJORD SE COCCIA PF
Citation: Nkv. Cheung et al., REASSESSMENT OF PATIENT RESPONSE TO MONOCLONAL-ANTIBODY 3F8, Journal of clinical oncology, 10(4), 1992, pp. 671-672
Risultati: 1-25 | 26-32